Cargando…

Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations

Detalles Bibliográficos
Autores principales: Ortiz, Michael V., Gerdemann, Ulrike, Raju, Sandya Govinda, Henry, Dahlia, Smith, Steve, Rothenberg, S. Michael, Cox, Michael C., Proust, Stéphanie, Bender, Julia Glade, Frazier, A. Lindsay, Anderson, Peter, Pappo, Alberto S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450975/
https://www.ncbi.nlm.nih.gov/pubmed/32923911
http://dx.doi.org/10.1200/PO.19.00401
_version_ 1783574897836949504
author Ortiz, Michael V.
Gerdemann, Ulrike
Raju, Sandya Govinda
Henry, Dahlia
Smith, Steve
Rothenberg, S. Michael
Cox, Michael C.
Proust, Stéphanie
Bender, Julia Glade
Frazier, A. Lindsay
Anderson, Peter
Pappo, Alberto S.
author_facet Ortiz, Michael V.
Gerdemann, Ulrike
Raju, Sandya Govinda
Henry, Dahlia
Smith, Steve
Rothenberg, S. Michael
Cox, Michael C.
Proust, Stéphanie
Bender, Julia Glade
Frazier, A. Lindsay
Anderson, Peter
Pappo, Alberto S.
author_sort Ortiz, Michael V.
collection PubMed
description
format Online
Article
Text
id pubmed-7450975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74509752020-09-30 Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations Ortiz, Michael V. Gerdemann, Ulrike Raju, Sandya Govinda Henry, Dahlia Smith, Steve Rothenberg, S. Michael Cox, Michael C. Proust, Stéphanie Bender, Julia Glade Frazier, A. Lindsay Anderson, Peter Pappo, Alberto S. JCO Precis Oncol Case Reports American Society of Clinical Oncology 2020-04-14 /pmc/articles/PMC7450975/ /pubmed/32923911 http://dx.doi.org/10.1200/PO.19.00401 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle Case Reports
Ortiz, Michael V.
Gerdemann, Ulrike
Raju, Sandya Govinda
Henry, Dahlia
Smith, Steve
Rothenberg, S. Michael
Cox, Michael C.
Proust, Stéphanie
Bender, Julia Glade
Frazier, A. Lindsay
Anderson, Peter
Pappo, Alberto S.
Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
title Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
title_full Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
title_fullStr Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
title_full_unstemmed Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
title_short Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
title_sort activity of the highly specific ret inhibitor selpercatinib (loxo-292) in pediatric patients with tumors harboring ret gene alterations
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450975/
https://www.ncbi.nlm.nih.gov/pubmed/32923911
http://dx.doi.org/10.1200/PO.19.00401
work_keys_str_mv AT ortizmichaelv activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT gerdemannulrike activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT rajusandyagovinda activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT henrydahlia activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT smithsteve activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT rothenbergsmichael activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT coxmichaelc activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT prouststephanie activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT benderjuliaglade activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT frazieralindsay activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT andersonpeter activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations
AT pappoalbertos activityofthehighlyspecificretinhibitorselpercatinibloxo292inpediatricpatientswithtumorsharboringretgenealterations